Hypopituitarism May Cause Insomnia, Reduced Libido, Depression
SEATTLE — For the 30% of warriors with concussive injuries whose symptoms fail to resolve in a few months, recent research offers new hope.

ANN ARBOR, MI — For nearly two years, the Food and Drug Administration has been issuing safety advisories about the risks of abnormal heart rhythms with higher doses of the antidepressant citalopram hydrobromide.

WASHINGTON — A House committee has voted to ban VA senior executives from receiving any bonuses for five years, citing claims backlogs and unresolved healthcare quality issues.

SAN ANTONIO, TX - Ten years ago, many of the survivors of the Boston Marathon bombing with major lower body injuries would likely have spent the rest of their lives in a wheelchair. A new - and far more positive - set of expectations have been established, however, because of 12 years of experience with improvised explosive devices (IEDs) gained in Iraq and Afghanistan.

Currently in Place for Radiology, Ophthalmology
WASHINGTON - Under pressure to develop an accurate method of assessing physician output and determining appropriate staffing levels at medical facilities, the VA has agreed to establish productivity models for five additional specialties by the end of this fiscal year.

Opinion poll:
Does VA have an appropriate number of specialty physicians to meet patient-care needs? Please click here to participate in this month's U.S. Medicine readership poll.

PPIs Used Too Long
CHICAGO - How VA patients are treated, or potentially overtreated, for gastroesophageal reflux disease (GERD) is coming under greater scrutiny.

New Research Indicates Water Contamination Began in 1953
WASHINGTON - Legislation signed into law in August was applauded for offering medical care through VA for veterans and family members exposed to contaminated drinking water at Camp Lejeune, NC.

SAN DIEGO - The Food and Drug Administration’s (FDA) recent approval of canagliflozin might soon offer new treatment options for the more than one million VA patients with diabetes.

BLAINVILLE, QUEBEC - Diclegis (doxylamine succinate and pyridoxine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat pregnant women experiencing nausea and vomiting.

DUBLIN, OH - The U.S. Food and Drug Administration recently approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, the first new drug used for lymph node mapping to be approved in more than 30 years.